Evidence map›Paper›PMID 27547682›Full record

ArticleSpringerPlus2016

Carbapenem resistant Pseudomonas aeruginosa and Acinetobacter baumannii at Mulago Hospital in Kampala, Uganda (2007-2009).

David P Kateete, Ritah Nakanjako, Juliet Namugenyi, Joseph Erume, Moses L Joloba, Christine F Najjuka

Open access · diamondAbstract read
In one paragraph

Article in SpringerPlus, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 4 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 4 syntheses or guidelines pooled it, 85 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. The intricacies ofFrontiers in microbiology · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Genotypic Characterization of Carbapenem-ResistantPathogens (Basel, Switzerland) · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

David P KateeteDepartment of Immunology and Molecular Biology, College of Health Sciences, Makerere University, Kampala, Uganda ; Department of Medical Microbiology, College of Health Sciences, Makerere University, Kampala, Uganda.
Ritah NakanjakoDepartment of Medical Microbiology, College of Health Sciences, Makerere University, Kampala, Uganda ; College of Veterinary Medicine, Animal Resources and Biosecurity, Makerere University, Kampala, Uganda.
Juliet NamugenyiDepartment of Medical Microbiology, College of Health Sciences, Makerere University, Kampala, Uganda ; College of Veterinary Medicine, Animal Resources and Biosecurity, Makerere University, Kampala, Uganda ; Makerere University-Johns Hopkins University (MU-JHU) Core Lab at the Infectious Diseases Institute (IDI), College of Health Sciences, Makerere University, Kampala, Uganda.
Joseph ErumeCollege of Veterinary Medicine, Animal Resources and Biosecurity, Makerere University, Kampala, Uganda.
Moses L JolobaDepartment of Immunology and Molecular Biology, College of Health Sciences, Makerere University, Kampala, Uganda ; Department of Medical Microbiology, College of Health Sciences, Makerere University, Kampala, Uganda.
Christine F NajjukaDepartment of Medical Microbiology, College of Health Sciences, Makerere University, Kampala, Uganda.
Makerere University · UG

Funding

CELL TO CELL SIGNALING IN MYCOBACTERIAR01AI075637 · NIAID · MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES · PI JOLOBA, MOSES LUTAAKOME · 2007 to 2010
$319k
ROLE OF RHOMBOID HOMOLOGUES IN MYCOBACTERIA SIGNALINGR03AI062849 · NIAID · MAKERERE MEDICAL SCHOOL · PI JOLOBA, MOSES LUTAAKOME · 2005 to 2006
$107k
NIAID NIH HHS R01 AI075637NIAID NIH HHS R03 AI062849
6 · The paper itself

Abstract

backgroundMultidrug resistant Pseudomonas aeruginosa and Acinetobacter baumannii are common causes of health care associated infections worldwide. Carbapenems are effective against infections caused by multidrug resistant Gram-negative bacteria including Pseudomonas and Acinetobacter species. However, their use is threatened by the emergence of carbapenemase-producing strains. The aim of this study was to determine the prevalence of carbapenem-resistant P. aeruginosa and A. baumannii at Mulago Hospital in Kampala Uganda, and to establish whether the hospital environment harbors carbapenem-resistant Gram-negative rods.

resultsBetween February 2007 and September 2009, a total of 869 clinical specimens were processed for culture and sensitivity testing yielding 42 (5 %) P. aeruginosa and 29 (3 %) A. baumannii isolates, of which 24 % (10/42) P. aeruginosa and 31 % (9/29) A. baumannii were carbapenem-resistant. Additionally, 80 samples from the hospital environment were randomly collected and similarly processed yielding 58 % (46/80) P. aeruginosa and 14 % (11/80) A. baumannii, of which 33 % (15/46) P. aeruginosa and 55 % (6/11) A. baumannii were carbapenem-resistant. The total number of isolates studied was 128. Carbapenemase genes detected were bla IMP-like (36 %, 9/25), bla VIM-like (32 %, 8/25), bla SPM-like (16 %, 4/25); bla NDM-1-like (4 %, 1/25) in carbapenem-resistant P. aeruginosa, and bla OXA-23-like (60 %, 9/15), bla OXA-24-like (7 %, 1/15), bla OXA-58-like (13 %, 2/15), and bla VIM-like (13 %, 2/15) in carbapenem-resistant A. baumannii. Furthermore, class 1 integrons were detected in 38 % (48/128) of P. aeruginosa and Acinetobacter, 37 % (26/71) of which were in clinical isolates and 39 % (22/57) in environment isolates. Gene cassettes were found in 25 % (12/48) of integron-positive isolates. These were aminoglycoside adenylyltransferase ant(4')-IIb (3 isolates); trimethoprim-resistant dihydrofolate reductase dfrA (2 isolates); adenyltransferase aadAB (3 isolates); QacE delta1 multidrug exporter (2 isolates); quinolone resistance pentapeptide repeat protein qnr (1 isolate); and metallo-β-lactamase genes bla VIM-4-like, bla IMP-19-like, and bla IMP-26-like (1 isolate each). Gene cassettes were missing in 75 % (36/48) of the integron-positive isolates.

conclusionsThe prevalence of carbapenem-resistant P. aeruginosa and Acinetobacter among hospitalized patients at Mulago Hospital is low compared to rates from South-East Asia. However, it is high among isolates and in the environment, which is of concern given that the hospital environment is a potential source of infection for hospitalized patients and health care workers.

Indexed as

Carbapenemase genesClass 1 integronsHospital environmentMetallo-beta-lactamasesOXA-carbapenemases

Identifiers

PMID27547682
PMCPMC4978656
OpenAlexW2517313720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.